• Loosening of Marijuana Laws Little Felt in Trucking Industry
  • May 13, 2019 | Author: Adam R. Dolan
  • Law Firm: Goldberg Segalla LLP - White Plains Office
  • A tectonic shift in marijuana laws nationally over the past five years has been little felt on America’s trucking routes, according to a Truckload Carriers Association webinar last week whose featured speakers included Goldberg Segalla partner Adam R. Dolan. Truck drivers still must test negative for marijuana use to get and keep their jobs, and fleets still must maintain drug-testing programs.

    These were among the webinar's key takeaways according to Commercial Carrier Journal, which covered the event. With cannabis classified federally as an illegal Schedule I substance – one seen as having no acceptable medical use and a high potential for abuse – the U.S. Department of Transportation continues rigidly enforcing its marijuana policies. Marijuana’s Schedule 1 classification lumps it together with drugs such as heroin, LSD, and peyote. For a trucker, failing a drug test for marijuana is automatically disqualifying, said Todd Simo, chief medical officer and vice president of business development for HireRight. “Period. No caveats.”

    This sets the trucking industry apart from the nation at large, where marijuana laws have loosened considerably. “Laws regarding marijuana have changed drastically in the last five to six years,” Adam said. All but a handful of states now allow for at some level of use, from limited medical access to broader legalization.

    Adam is a member of Goldberg Segalla’s Trucking practice group, an experienced, full-service team dedicated to providing trucking and transportation-focused companies with all the counsel and representation they need. In addition, Adam is founder and co-chair of the firm's Cannabis Law practice. Recognized by Data Bird as a Cannabis Law Expert in 2018 and by the National Law Journal as a Cannabis Law Trailblazer in 2019, Adam is widely recognized as a leading source of informed analysis on evolving legal issues related to cannabis and business concerns across numerous industries. He frequently writes on this subject for the firm's Life Science Matters blog.

    Read more in Commercial Carrier Journal: